Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD)
Publication
, Conference
Poe, J; diPaolo, J; Jia, W; Kim, JY; Su, H; Reyes, N; Marcondes, AM; Saban, D; Cardona, D; Anand, S; Cardones, A; Chao, N; Sarantopoulos, S
Published in: BONE MARROW TRANSPLANTATION
July 1, 2017
Duke Scholars
Published In
BONE MARROW TRANSPLANTATION
EISSN
1476-5365
ISSN
0268-3369
Publication Date
July 1, 2017
Volume
52
Start / End Page
S46 / S46
Location
Marseille, FRANCE
Publisher
NATURE PUBLISHING GROUP
Conference Name
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)
Related Subject Headings
- Immunology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Poe, J., diPaolo, J., Jia, W., Kim, J. Y., Su, H., Reyes, N., … Sarantopoulos, S. (2017). Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD). In BONE MARROW TRANSPLANTATION (Vol. 52, pp. S46–S46). Marseille, FRANCE: NATURE PUBLISHING GROUP.
Poe, J., J. diPaolo, W. Jia, J. Y. Kim, H. Su, N. Reyes, A. M. Marcondes, et al. “Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD).” In BONE MARROW TRANSPLANTATION, 52:S46–S46. NATURE PUBLISHING GROUP, 2017.
Poe J, diPaolo J, Jia W, Kim JY, Su H, Reyes N, et al. Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD). In: BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP; 2017. p. S46–S46.
Poe, J., et al. “Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD).” BONE MARROW TRANSPLANTATION, vol. 52, NATURE PUBLISHING GROUP, 2017, pp. S46–S46.
Poe J, diPaolo J, Jia W, Kim JY, Su H, Reyes N, Marcondes AM, Saban D, Cardona D, Anand S, Cardones A, Chao N, Sarantopoulos S. Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD). BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP; 2017. p. S46–S46.
Published In
BONE MARROW TRANSPLANTATION
EISSN
1476-5365
ISSN
0268-3369
Publication Date
July 1, 2017
Volume
52
Start / End Page
S46 / S46
Location
Marseille, FRANCE
Publisher
NATURE PUBLISHING GROUP
Conference Name
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)
Related Subject Headings
- Immunology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences